anmelden
SMI Expanded
1.971,54
PKT
+34,79
PKT
+1,80
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.10.14 | Roche buy | Citigroup Corp. | |
| 22.10.14 | ABB (Asea Brown Boveri) buy | S&P Capital IQ | |
| 20.10.14 | Givaudan buy | UBS AG | |
| 20.10.14 | Roche overweight | JP Morgan Chase & Co. | |
| 17.10.14 | Nestlé Neutral | Goldman Sachs Group Inc. | |
| 17.10.14 | Nestlé overweight | Morgan Stanley | |
| 17.10.14 | Nestlé Halten | Independent Research GmbH | |
| 17.10.14 | Nestlé Neutral | BNP PARIBAS | |
| 17.10.14 | Nestlé Neutral | UBS AG | |
| 16.10.14 | Roche Hold | S&P Capital IQ | |
| 16.10.14 | Nestlé Sell | S&P Capital IQ | |
| 16.10.14 | Roche kaufen | Independent Research GmbH | |
| 16.10.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 16.10.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 16.10.14 | UBS Halten | Independent Research GmbH | |
| 16.10.14 | Novartis Equal weight | Barclays Capital | |
| 15.10.14 | Roche overweight | Barclays Capital | |
| 15.10.14 | Holcim buy | UBS AG | |
| 15.10.14 | Holcim buy | UBS AG | |
| 15.10.14 | Swiss Re market-perform | Bernstein Research | |
| 14.10.14 | UBS Buy | UBS AG | |
| 14.10.14 | Roche buy | Citigroup Corp. | |
| 14.10.14 | UBS buy | Société Générale Group S.A. (SG) | |
| 14.10.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 14.10.14 | Nestlé overweight | JP Morgan Chase & Co. | |
| 14.10.14 | Novartis Underweight | Morgan Stanley | |
| 13.10.14 | ABB (Asea Brown Boveri) Outperform | Credit Suisse Group | |
| 13.10.14 | UBS overweight | JP Morgan Chase & Co. | |
| 13.10.14 | Holcim buy | Deutsche Bank AG | |
| 13.10.14 | Roche overweight | JP Morgan Chase & Co. | |
| 13.10.14 | Swiss Re buy | Jefferies & Company Inc. | |
| 13.10.14 | Roche buy | UBS AG | |
| 10.10.14 | Nestlé buy | Citigroup Corp. | |
| 09.10.14 | Nestlé Neutral | UBS AG | |
| 09.10.14 | Givaudan buy | UBS AG | |
| 09.10.14 | Holcim buy | Deutsche Bank AG | |
| 08.10.14 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 08.10.14 | Givaudan Outperform | Credit Suisse Group | |
| 08.10.14 | Novartis Hold | Deutsche Bank AG | |
| 07.10.14 | Roche buy | UBS AG |